Article Details

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Given Average Recommendation of "Buy" by ...

Retrieved on: 2021-03-15 12:45:00

Tags for this article:

Click the tags to see associated articles and topics

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Given Average Recommendation of "Buy" by .... View article details on hiswai:

Excerpt

Renaissance Technologies LLC now owns 144,000 shares of the company's stock valued at $475,000 after buying an additional 125,400 shares in the ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up